熱門資訊> 正文
Envoy Medical GAAP每股收益为-0.27美元
2024-08-13 22:48
- Envoy Medical press release (NASDAQ:COCH): Q2 GAAP EPS of -$0.27.
- Revenue was $68K compared to $63K for the same period in 2023.
- As of June 30, 2024, the company had cash and cash equivalents of approximately $1.7M
- Shares -4.05%.
More on Envoy Medical
- Envoy Medical Is Pursuing Filling A Hearing Industry Void
- Seeking Alpha’s Quant Rating on Envoy Medical
- Historical earnings data for Envoy Medical
- Financial information for Envoy Medical
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
